Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Characterization and in vivo testing of mesenchymal stem cells derived from human embryonic stem cells.

Gruenloh W, Kambal A, Sondergaard C, McGee J, Nacey C, Kalomoiris S, Pepper K, Olson S, Fierro F, Nolta JA.

Tissue Eng Part A. 2011 Jun;17(11-12):1517-25. doi: 10.1089/ten.TEA.2010.0460. Epub 2011 Mar 4.

2.

Human embryonic stem cell-derived mesenchymal progenitors: an overview.

Hematti P.

Methods Mol Biol. 2011;690:163-74. doi: 10.1007/978-1-60761-962-8_11. Review.

PMID:
21042992
3.

Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.

Chamberlain G, Fox J, Ashton B, Middleton J.

Stem Cells. 2007 Nov;25(11):2739-49. Epub 2007 Jul 26. Review.

4.

Mesenchymal stem cells: Identification, phenotypic characterization, biological properties and potential for regenerative medicine through biomaterial micro-engineering of their niche.

Kobolak J, Dinnyes A, Memic A, Khademhosseini A, Mobasheri A.

Methods. 2016 Apr 15;99:62-8. doi: 10.1016/j.ymeth.2015.09.016. Epub 2015 Sep 15. Review.

PMID:
26384580
5.

Implications of mesenchymal stem cells in regenerative medicine.

Kariminekoo S, Movassaghpour A, Rahimzadeh A, Talebi M, Shamsasenjan K, Akbarzadeh A.

Artif Cells Nanomed Biotechnol. 2016 May;44(3):749-57. doi: 10.3109/21691401.2015.1129620. Epub 2016 Jan 13. Review.

PMID:
26757594
6.

Isolation of mesenchymal stem cells from human placental decidua basalis and resistance to hypoxia and serum deprivation.

Huang YC, Yang ZM, Chen XH, Tan MY, Wang J, Li XQ, Xie HQ, Deng L.

Stem Cell Rev. 2009 Sep;5(3):247-55. doi: 10.1007/s12015-009-9069-x. Epub 2009 May 23. Review.

PMID:
19590988
7.

Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment.

Brennen WN, Denmeade SR, Isaacs JT.

Endocr Relat Cancer. 2013 Aug 23;20(5):R269-90. doi: 10.1530/ERC-13-0151. Print 2013 Oct. Review.

8.

Reviewing and updating the major molecular markers for stem cells.

Calloni R, Cordero EA, Henriques JA, Bonatto D.

Stem Cells Dev. 2013 May 1;22(9):1455-76. doi: 10.1089/scd.2012.0637. Epub 2013 Jan 22. Review.

9.

Engineered adenosine-releasing cells for epilepsy therapy: human mesenchymal stem cells and human embryonic stem cells.

Boison D.

Neurotherapeutics. 2009 Apr;6(2):278-83. doi: 10.1016/j.nurt.2008.12.001. Review.

10.

Mesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic Nephropathy.

Paulini J, Higuti E, Bastos RM, Gomes SA, Rangel √ČB.

Stem Cells Int. 2016;2016:9521629. doi: 10.1155/2016/9521629. Epub 2016 Dec 13. Review.

11.

Recent Advances and Future Direction in Lyophilisation and Desiccation of Mesenchymal Stem Cells.

Bissoyi A, Kumar A, Rizvanov AA, Nesmelov A, Gusev O, Patra PK, Bit A.

Stem Cells Int. 2016;2016:3604203. doi: 10.1155/2016/3604203. Epub 2016 Aug 14. Review.

Supplemental Content

Support Center